Researchers develop 'three-headed hydra' for anti-cancer activity
October 22, 2021 -- A "three-headed hydra" significantly improves efficacy in targeted protein degradation, according to research published October 21 in Nature Chemical Biology Read More
I-Mab establishing new site in San Diego
October 22, 2021 -- I-Mab is establishing a new site in San Diego that will focus on translational medicine and formulation research, the company announced. I-Mab did not indicate when the site would be operational. Read More
EY launches smart reviewer
October 22, 2021 -- Ernst & Young (EY) is launching the EY Smart Reviewer, software that utilizes artificial intelligence and natural language processing to help companies review materials used to market pharmaceutical and medical device products. Read More
Salmonella shows promise as cancer therapy
October 22, 2021 -- Salmonella may be useful as a bacterial delivery vector for cancer therapy, according to research published October 21 in Nature Communications. Read More
FDA authorizes COVID-19 vaccine booster shots
October 21, 2021 -- Johnson & Johnson and Moderna have received emergency use authorization from the U.S. Food and Drug Administration (FDA) for booster shots of their COVID-19 vaccines. Read More
FDA grants orphan drug designation to Intellia's NTLA-2001
October 21, 2021 -- The U.S. Food and Drug Administration has granted an orphan drug designation to Intellia Therapeutics' NTLA-2001 therapy for the treatment of transthyretin amyloidosis. Read More
Waters, U. of Delaware to collaborate on biopharma processing
October 21, 2021 -- Waters and the University of Delaware have initiated a five-year collaboration focused on improving quality, yields, and efficiency in the manufacturing processes for biologics and new modalities. Read More
Selecta and Genovis enter exclusive license agreement
October 21, 2021 -- Selecta Biosciences and Genovis have inked a strategic licensing agreement to advance a next-generation immunoglobulin G protease for use in gene therapy and certain autoimmune diseases. Read More
Unchained Labs launches new automation software
October 20, 2021 -- Unchained Labs has released its LEA 10 automation software, which aims to enable researchers to navigate workflow bottlenecks and scientific challenges. Read More
Prime Medicine expands gene editing platform
October 19, 2021 -- Prime Medicine has added new capabilities to its Prime gene editing platform based on new research developments. Read More
Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter